After a seven-year battle, pharmaceutical manufacturers AstraZeneca, Cephalon, and Biogen Idec have agreed to pay $55.5 million to settle a whistleblower-initiated False Claims Act case.

FCA | AstraZeneca, Berger & Montague, P.C., Faruqi & Faruqi, LLP, T. Talyana Bromberg